Metolazone Tablet
NDC Package 0185-5600-10

11-digit billing NDC: 00185560010

Package Information

Metolazone tablets is metolazone is indicated for the treatment of salt and water retention including:•  edema accompanying congestive heart failure;•  edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function.Metolazone is also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. This formulation utilizes a tablet delivery system. Marketed by Sandoz Inc, this product is identified by NDC 0185-5600 and is authorized under FDA application ANDA076466.

Identification & Billing

NDC Package Code
0185-5600-10
Package Description
1000 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
00185560010
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Metolazone
Non-Proprietary Name
Metolazone
Substance Name
Metolazone
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Metolazone is indicated for the treatment of salt and water retention including:•  edema accompanying congestive heart failure;•  edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function.Metolazone is also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. Mykrox® tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. A dose titration is necessary if Mykrox® tablets are to be substituted for Zaroxolyn® tablets and other formulations of metolazone that share its slow and incomplete bioavailability, in the treatment of hypertension.

Regulatory & Marketing

Labeler Name
Sandoz Inc
Product Type
Human Prescription Drug
FDA Application #
ANDA076466
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-19-2003
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0185-5600). Click a package code to view its specific billing and regulatory data.

100 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0185-5600-10 identifies a specific commercial package of 1000 tablet in 1 bottle of Metolazone, a human prescription drug labeled by Sandoz Inc. This tablet is formulated for oral use and contains metolazone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sandoz Inc on December 19, 2003. The current certification is valid through December 31, 2027.

How is this Sandoz Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00185560010. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0185-5600-10
11-Digit CMS (5-4-2)
00185-5600-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.